Sarepta's Duchenne gene therapy slows disease progression at three years

By Mariam Sunny Jan 26 (Reuters) - Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy slowed disease ...
Manistee News Advocate on MSN

AMISH KITCHEN: Daughter Verena discusses her disability

"Muscular dystrophy can take many things from me, but it will not take away my happiness, nor will it take away my faith." ...
KSDK

'You won't be alone': Families unite at Forest Park for MDA Muscle Walk

ST. LOUIS — On a cloudy morning in Forest Park, families gathered not just to take steps together but to take them for each other. The Muscular Dystrophy Association's 2025 Muscle Walk on May 4 drew ...
Charity Today

Fundraising Father goes the distance for son living with Duchenne muscular dystrophy

The father-of-two, Rich Clift, 38, will take on the 100km walk (spanning two days 16 - 17 May 2026), along with three others including brothers-in-law, Ashley ...
Healio

Gene therapy improves functional outcomes for boys with Duchenne muscular dystrophy

Please provide your email address to receive an email when new articles are posted on . RGX-202 was safe and well-tolerated in all 12 patients at two different doses with no serious adverse events.

muscular dystrophy

Disability advocate TaLisha Gryzb is a mother of four living with muscular dystrophy who educates viewers about her ...
The Boston Globe

Sarepta reports second patient death after treatment with Duchenne gene therapy

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Cambridge-based Sarepta Therapeutics said ...